Contact us

Milling CDMO Companies
Jet, Pin & Cryogenic Milling Services

Your Trusted Partners for Pharmaceutical Milling and Particle Size Reduction

Showing 2 facilities
Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

An USFDA approved API & Intermediate Manufacturing facility.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Chemical-Pharmaceutical Facility

Location available after registration

Suggested Results

These facilities match your main criteria but not every optional filter — including other countries in the same region.

Avara Pharmaceutical Services | Arecibo Site
United States

Avara Pharmaceutical Services | Arecibo Site

AVARA

Commercial-scale oral solid dosage (OSD) manufacturing facility with strong expertise in controlled substances (DEA II V).

BATCH SIZE: Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP), ICH

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada)

USE: Human

SERVICES: Analytical / QC services, Manufacturing services, Packaging, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

REGION: North America

Avara Pharmaceutical Services | Norman Site
United States

Avara Pharmaceutical Services | Norman Site

AVARA

Contract manufacturing facility specialized in Oral Solid Dosage (OSD) for clinical and commercial supply.

BATCH SIZE: Small, Medium, Large

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (N) Nervous system, (B) Blood and blood forming organs

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

COMPLIANCE: Roszdravnadzor (Russia GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MHRA (UK GMP), TGA (Australia GMP), FDA (cGMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP), ICH

CONTROLLED SUBSTANCES: Lowest potential for abuse, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), Russian Health Authorities, EMA (EU), MFDS (South Korea), TGA (Australia), Health Canada (Canada), MHRA (UK)

USE: Human

SERVICES: Analytical / QC services, Manufacturing services, Development services, Packaging, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

REGION: North America

CARBOGEN AMCIS | Manchester, UK
United Kingdom

CARBOGEN AMCIS | Manchester, UK

CARBOGEN AMCIS

Discover our cosmetic ingredient manufacturing capabilities, fine chemicals and custom synthesis of pharma intermediates capabilities.

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: SERVICES, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC

REGION: Europe

SERVICES: Analytical / QC services, Manufacturing services, Development services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: ECOVADIS, ISO, Halal Research Council

CARBOGEN AMCIS | Aarau
Switzerland

CARBOGEN AMCIS | Aarau

CARBOGEN AMCIS

Development and medium scale cGMP manufacturing including chromatography.

BATCH SIZE: Small, Medium

COMPLIANCE: PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC

REGION: Europe

MARKETS: ANVISA (Brazil), PMDA (Japan), FDA (USA), CDSCO (India), EMA (EU), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), MHRA (UK)

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CARBOGEN AMCIS | Bubendorf
Switzerland

CARBOGEN AMCIS | Bubendorf

CARBOGEN AMCIS

Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC).

MARKETS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)

BATCH SIZE: Small, Medium

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs

COMPLIANCE: EMA (EU GMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), FDA (cGMP), ISO

CATEGORY / PRODUCT: SERVICES, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC

REGION: Europe

USE: Human, Veterinary

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

PHARMALOOP S.L. - a Salvat Company
Spain

PHARMALOOP S.L. - a Salvat Company

Laboratorios Salvat

Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

COMPLIANCE: EMA (EU GMP), FDA (cGMP), ISO

REGION: Europe

USE: Human

SERVICES: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services

MARKETS: FDA (USA), EMA (EU)

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V01) Allergens, (S) Sensory organs

BSL (Biological Safety Level): 1

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Limited view

PARTICLE ENGINEERING manufacturing site

MAI network supplier

An API and Interemediate manufacturer having global certifications.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Dry Powder Inhalation Plant.

Location available after registration

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Your trusted GMP CDMO for advanced aseptic and non-aseptic pharmaceutical drug product manufacturing, formulation development, and analytical testing.

Location available after registration

Particle size reduction plays a critical role in drug performance, bioavailability, and manufacturability. As formulations become more complex, partnering with specialized milling CDMO companies is essential to achieve precise and reproducible particle engineering. These contract development and manufacturing organizations provide advanced milling technologies and controlled processes to support pharmaceutical development and commercial manufacturing.

Whether you require micronization of poorly soluble APIs or controlled particle size distribution for solid dosage forms, experienced pharmaceutical milling CDMOs deliver scalable, compliant, and high-precision milling solutions.


How to Choose Milling CDMO Companies

Selecting the right milling CDMO is key to ensuring product quality and downstream process success. Important factors to evaluate include:

  • Jet milling expertise: Proven experience in fluidized-bed and spiral jet milling for micronization.
  • Pin milling capabilities: Controlled size reduction for granules, excipients, and APIs.
  • Cryogenic milling know-how: Milling of heat-sensitive or elastic materials using liquid nitrogen.
  • Containment and safety: Capabilities for highly potent APIs (HPAPIs) and controlled substances.
  • Scalability: Ability to move from lab-scale and pilot batches to commercial production.
  • GMP compliance: Facilities and quality systems aligned with FDA, EMA, and global standards.

A specialized milling partner reduces technical risk and ensures consistent particle size distribution across development stages.


Key Services Offered by Milling Contract Manufacturers

Leading milling contract manufacturing providers typically offer:

  • Jet milling (micronization): Ultra-fine particle size reduction for poorly soluble APIs.
  • Pin milling: Medium-fine milling for powders and granulated materials.
  • Cryogenic milling: Milling of thermolabile, sticky, or elastic materials.
  • Particle size distribution control and optimization.
  • Process development and scale-up
  • Analytical characterization: PSD, morphology, and flow properties.
  • GMP milling services: For clinical and commercial supply.
  • Containment milling: For potent and hazardous compounds.

These services support formulation development, bioavailability enhancement, and robust downstream processing.


Advantages of Partnering with Milling CDMO Companies

Working with specialized milling CDMO companies provides several advantages:

  • Improved bioavailability: Through precise particle size reduction.
  • Process consistency: Reproducible milling results across batches.
  • Formulation flexibility: Tailored PSD for tablets, capsules, inhalation, and suspensions.
  • Reduced thermal and mechanical stress: Especially with cryogenic milling.
  • Regulatory confidence: GMP-compliant milling processes and documentation.

These CDMOs act as technical partners, ensuring milling performance aligns with formulation and regulatory requirements.


Milling CDMO Companies

  • PHARMALOOP: Fully integrated CDMO solutions for milling, sachets, capsules and tablets. [See CDMO profile]
  • Ascendia Pharmaceutical Solutions: Your trusted GMP CDMO for advanced aseptic and non-aseptic pharmaceutical drug product manufacturing, including milling CDMO services, formulation development, and analytical testing. [See CDMO profile]

Related Information


Let MAI CDMO Network Help You Find the Right Milling CDMO Partner

At MAI CDMO Network, we connect pharmaceutical and biotech companies with trusted milling CDMO companies worldwide. Whether you need jet milling, pin milling, or cryogenic milling services, our network of specialized pharmaceutical milling CDMOs ensures technical fit, regulatory compliance, and reliable supply.

Looking for a precision milling partner? Contact us today to find the right CDMO for your particle engineering needs.